Funding for this research was provided by:
National Human Genome Research Institute (1K99HG009916-01)
National Institute of General Medical Sciences (R01GM122924)
National Institute of Mental Health (R01MH101814, R01MH106842)
National Institutes of Health (5UL1 TR001114-05, UL1TR002550-01, 1U24DK112331, UM1HG008901)
Received: 24 September 2019
Accepted: 27 July 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: Not applicable.
: F.A. is an inventor on a patent application related to TensorQTL; S.E.C. is a co-founder, Chief Technology Officer, and stock owner at Variant Bio; T.L. is an advisory board member of Variant Bio with equity and Goldfinch Bio.